Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Raloxifene, identified as a novel LSD1 inhibitor, suppresses the migration of renal cell carcinoma
Yuan Ma, Yan Zheng, Yanli Ji, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 6, pp. 533-542
Open Access | Times Cited: 9

Showing 9 citing articles:

Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021
Yihui Song, Huiqing Zhang, Xiaoke Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 114042-114042
Closed Access | Times Cited: 45
Inflammatory Networks in Renal Cell Carcinoma
Linus Kruk, Medina Mamtimin, Attila Braun, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2212-2212
Open Access | Times Cited: 16
Lysine-Specific Demethylase 1 Inhibitors: A Comprehensive Review Utilizing Computer-Aided Drug Design Technologies
Di Han, Jiarui Lu, Baoyi Fan, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 550-550
Open Access | Times Cited: 6
Discovery of a selective and reversible LSD1 inhibitor with potent anticancer effects in vitro and in vivo
Xiaosong Zhang, Jin-Zhan Liu, Yadong Mei, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present)
Xingrui He, Hang Zhang, Yingqian Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114143-114143
Closed Access | Times Cited: 17
Stilbenes: a promising small molecule modulator for epigenetic regulation in human diseases
Jing Tian, Jin Li, Hongquan Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Investigation of the potential effects of estrogen receptor modulators on immune checkpoint molecules
Nikita Abramenko, F.M.D. Vellieux, Kateřina Veselá, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Arborinine from Glycosmis parva leaf extract inhibits clear-cell renal cell carcinoma by inhibiting KDM1A/UBE2O signaling
Chenchen Feng, Lingxiao Gong, Jing Wang
Food & Nutrition Research (2022) Vol. 66
Open Access | Times Cited: 8
Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma
Shuai Liu, Yu Yao, Mingyu Hou, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Page 1

Scroll to top